əˌzoʊlɪdiːnˈdaɪ.oʊn/, abbreviated as TZD, also known as glitazones after the prototypical drug ciglitazone, are a class of heterocyclic compounds consisting of ...

Nov 27, 2019 · Purpose of Review. Thiazolidinediones (TZDs) are the only pharmacologic agents that specifically treat insulin resistance.

Thiazolidinediones (also called glitazones) are a class of medicines that may be used for the treatment of type 2 diabetes. They are a type of oral ...

The thiazolidinediones (TZDs) are a relatively new class of insulin-sensitizing drugs that have been introduced primarily for the control of type 2 diabetes ...

Thiazolidinediones (TZD) are peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists that improve peripheral insulin sensitivity by increasing ...

May 26, 2019 · Thiazolidinediones (rosiglitazone, pioglitazone) are oral insulin-sensitizing medications used in type 2 diabetes mellitus that reduce ...

INTRODUCTION. The thiazolidinediones increase insulin sensitivity by acting on adipose, muscle, and, to a lesser extent, liver to increase glucose ...

Dec 9, 2003 · TZDs may interact synergistically with insulin to cause arterial vasodilatation, leading to sodium reabsorption with a subsequent increase in ...